Dendrobium alkaloids decrease Aβ by regulating α- and β-secretases in hippocampal neurons of SD rats

Area of Science:

• Neuroscience
• Pharmacology
• Biochemistry

Background:

• Alzheimer's disease (AD) is a leading cause of dementia, characterized by amyloid-beta (Aβ) imbalance.
• Dendrobium nobile Lindl. alkaloids (DNLA) show anti-aging and neuroprotective effects, improving memory in mice.
• The precise mechanism of DNLA's neuroprotective action, particularly concerning Aβ, remains unclear.

Purpose of the Study:

• To investigate the effect of DNLA on amyloid-beta (Aβ) production in hippocampal neurons.
• To elucidate the underlying molecular mechanisms of DNLA's potential therapeutic benefits for Alzheimer's disease.

Main Methods:

• Cultured rat hippocampal neurons were treated with DNLA.
• Cell viability was assessed using MTT assays.
• Protein expression levels of key molecules (APP, ADAM10, BACE1, ADAM17, Aβ) were analyzed via Western blot.

Main Results:

• DNLA treatment did not significantly alter hippocampal neuron viability.
• DNLA reduced the protein expression of amyloid precursor protein (APP), ADAM10, BACE1, and Aβ₁₋₄₂.
• DNLA increased the protein expression of ADAM17.

Conclusions:

• DNLA effectively decreases amyloid-beta (Aβ) levels in rat hippocampal neurons.
• DNLA achieves this by modulating the activity of α-secretase and β-secretase pathways.
• These findings highlight DNLA's potential as a therapeutic agent for Alzheimer's disease.